Impaired glucose-induced glucagon suppression after partial ...

References:
1. Meier JJ, Butler PC 2005 Insulin secretion. In: DeGroot LJ, Jameson JL eds.
Endocrinology. 5 ed. Philadelphia: Elsevier Saunders; 961-973
2. Unger RH, Aguilar-Parada E, Muller WA, Eisentraut AM 1970 Studies of
pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 49:837-
848.
3. Lefebvre PJ 1995 Glucagon and its family revisited. Diabetes Care 18:715-730.
4. Dunning BE, Gerich JE 2007 The role of alpha-cell dysregulation in fasting and
postprandial hyperglycemia in type 2 diabetes and therapeutic implications. Endocr
Rev 28:253-283. Epub 2007 Apr 2004.
5. Sherwin RS, Fisher M, Hendler R, Felig P 1976 Hyperglucagonemia and blood
glucose regulation in normal, obese and diabetic subjects. N Engl J Med 294:455-461.
6. Raskin P, Unger RH 1978 Hyperglucagonemia and its suppression. Importance in
the metabolic control of diabetes. N Engl J Med 299:433-436.
7. Larsson H, Ahren B 2000 Glucose intolerance is predicted by low insulin secretion
and high glucagon secretion: outcome of a prospective study in postmenopausal
Caucasian women. Diabetologia 43:194-202.
8. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J
1992 Role of reduced suppression of glucose production and diminished early insulin
release in impaired glucose tolerance. N Engl J Med 326:22-29.
9. Bennett PH, Aronoff SL, Unger RH 1976 Evidence for an insulin-independent
alpha-cell abnormality in human diabetes. Metabolism 25:1527-1529.
10. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH 1973 Lack of
glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic
alpha cell defect. Science 182:171-173.
11. Kirk RD, Dunn P, Smith JR, Beaven DW, Donald RA 1975 Abnormal pancreatic
alpha-cell function in first-degree relatives of known diabetics. J Clin Endocrinol
Metab 40:913-916.
12. Meier JJ, Deacon CF, Schmidt WE, Holst JJ, Nauck MA 2007 Suppression of
glucagon secretion is lower after oral glucose administration than during intravenous
glucose administration in human subjects. Diabetologia 50:806-813. Epub 2007 Feb
2016.
13. Jayapaul MK, Walker M 2007 Hyperglucagonaemia is not a primary metabolic
defect in non-diabetic first-degree relatives from Type 2 diabetic families. Diabet Med
24:1050-1051.
14. Raju B, Cryer PE 2005 Loss of the decrement in intraislet insulin plausibly explains
loss of the glucagon response to hypoglycemia in insulin-deficient diabetes:
documentation of the intraislet insulin hypothesis in humans. Diabetes 54:757-764.
15. Kjems LL, Kirby BM, Welsh EM, Veldhuis JD, Straume M, McIntyre SS, Yang
D, Lefebvre P, Butler PC 2001 Decrease in beta-cell mass leads to impaired pulsatile
insulin secretion, reduced postprandial hepatic insulin clearance, and relative
hyperglucagonemia in the minipig. Diabetes 50:2001-2012
16. Goodner CJ, Koerker DJ, Weigle DS, McCulloch DK 1989 Decreased insulin- and
glucagon-pulse amplitude accompanying beta-cell deficiency induced by streptozocin
in baboons. Diabetes 38:925-931.
17. Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC 2006 Postprandial
suppression of glucagon secretion depends on intact pulsatile insulin secretion: Further
evidence for the intraislet insulin hypothesis. Diabetes 55:1051-1056
15